{
  "nctId": "NCT02450760",
  "briefTitle": "Connected Health Blood Pressure Monitoring In Stroke and TIA Patients",
  "protocolDocument": {
    "nctId": "NCT02450760",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2016-09-26",
    "uploadDate": "2021-07-29T09:10",
    "size": 930847,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02450760/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 33,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2015-11",
    "completionDate": "2021-07",
    "primaryCompletionDate": "2018-07",
    "firstSubmitDate": "2015-05-18",
    "firstPostDate": "2015-05-21"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Adult, age ≥ 18 years\n* History of ischemic stroke or high risk TIA (defined by ABCD2 ≥ 4)between 2 weeks and 12 months prior to enrollment\n* Hypertensive at time of enrollment, defined by SBP\\>140 mm Hg or DBP \\>90 mm Hg at the time of study screening\n* Must own a smart phone capable of interacting with the connected blood pressure cuff (Apple iPhone 3GS or higher; Android 4.0 or higher with Bluetooth connectivity)\n* Willingness and ability to sign informed consent by patient\n\nExclusion Criteria:\n\n* Moderate or severe disability, defined by modified Rankin Scale ≥ 3.\n* Expected residence in a rehabilitation hospital, nursing facility or assisted living community during the study period.\n* Upper arm circumference \\<9 inches or \\>17 inches\n* Inability to monitor BP in both of the upper arms (i.e. history of bilateral radical mastectomy, bilateral severe subclavian stenosis, or bilateral arterial venous fistulas for dialysis).\n* Blood pressure discrepancy between arms of \\>10 mm Hg.\n* Inability to follow-up at 90 days and return BP monitor\n* Active participation in another clinical trial\n* Pregnant women",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Adherence With Home Blood Pressure Monitoring, Defined by the Proportion of Home Blood Pressure Recordings Successfully Completed",
        "description": "Percentage of requested blood pressure measurements completed. Note that subjects were enrolled for 90 +/- 7 days, and so this calculation was completed at day 83, rather than day 90.",
        "timeFrame": "90 Days"
      }
    ],
    "secondary": [
      {
        "measure": "Change in Systolic Blood Pressure Over Study Period",
        "description": "Difference in systolic blood pressure from the first 7 days of measurement to the last 7 days of measurement for each subject",
        "timeFrame": "90 days"
      },
      {
        "measure": "Number of Physician Visits",
        "timeFrame": "90 days"
      },
      {
        "measure": "Number of Emergency Department Visits",
        "timeFrame": "90 days"
      },
      {
        "measure": "Number of Changes in Antihypertensive Medications (Dose Adjustment or Addition of a New Agent)",
        "timeFrame": "90 days"
      },
      {
        "measure": "Number of Participates That Perceived the Blood Pressure Monitoring Device to be Easy to Use",
        "description": "Number of patients who felt that device was easy or very easy to use",
        "timeFrame": "90 days"
      },
      {
        "measure": "Number of Patients That Perceived Blood Pressure Monitoring to be Useful",
        "description": "Number of participants who felt that BP monitoring was useful or very useful",
        "timeFrame": "90 days"
      },
      {
        "measure": "Number of Patients Who Felt They Had Well-controlled Blood Pressure",
        "description": "Patients perception of whether or not BP was well controlled",
        "timeFrame": "90 days"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 7,
      "otherCount": 0,
      "totalCount": 8
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": false,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 59,
    "complexityCategory": "Complex"
  },
  "collectionDate": "2025-09-22T02:29:37.568Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}